Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2300 of 2529 entries
View as:

An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Phase: N/A Priority: Normal
NCT ID: NCT01908816 Org: User:
Start: 09/26/13 End: 01/08/16 Due: 01/08/17

Study to Determine and Evaluate a Safe and Tolerated Dose of HDM201 in Patients With Selected Advanced Tumors That Are TP53wt

Phase: N/A Priority: Normal
NCT ID: NCT02143635 Org: User:
Start: 07/07/14 End: 06/09/20 Due: 06/09/21

A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China

Phase: N/A Priority: Normal
NCT ID: NCT05388916 Org: User:
Start: 09/08/22 End: 02/27/25 Due: 02/27/26

Characterizing the Use of Ofatumumab in a Real World Setting

Phase: N/A Priority: Normal
NCT ID: NCT05090033 Org: User:
Start: 12/08/22 End: 12/31/25 Due: 12/31/26

Study of Safety and Efficacy of Genome-edited Hematopoietic Stem and Progenitor Cells in Sickle Cell Disease (SCD)

Phase: N/A Priority: Normal
NCT ID: NCT04443907 Org: User:
Start: 08/25/20 End: 01/06/25 Due: 01/06/26

Managed Access Programs for INC424, Ruxolitinib

Phase: N/A Priority: Normal
NCT ID: NCT04745637 Org: User:
Start: - End: - Due: -

Study of Tisagenlecleucel in Chinese Pediatric and Young Adult Subjects With Relapsed or Refractory B-cell ALL

Phase: N/A Priority: Normal
NCT ID: NCT04156659 Org: User:
Start: 11/30/21 End: 11/30/27 Due: 11/30/28

A 12-week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation

Phase: N/A Priority: Normal
NCT ID: NCT01712516 Org: User:
Start: 12/31/12 End: 02/28/14 Due: 02/28/15

Study of Efficacy and Safety of Twice Daily Oral Iptacopan (LNP023) in Adult PNH Patients Who Are Naive to Complement Inhibitor Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04820530 Org: User:
Start: 07/19/21 End: 04/18/23 Due: 04/18/24

Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01007942 Org: User:
Start: 10/31/09 End: 06/30/15 Due: 06/30/16

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Phase: N/A Priority: Normal
NCT ID: NCT01155453 Org: User:
Start: 04/30/10 End: 11/30/14 Due: 11/30/15

An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT00239044 Org: User:
Start: 12/31/02 End: - Due: -

Effect of Valsartan Compared to Enalapril on Sitting Systolic Blood Pressure in Children With High Blood Pressure

Phase: N/A Priority: Normal
NCT ID: NCT00433836 Org: User:
Start: 01/31/07 End: 02/28/09 Due: 02/28/10

A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT02201290 Org: User:
Start: 06/18/13 End: 07/04/17 Due: 07/04/18

To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

Phase: N/A Priority: Normal
NCT ID: NCT01302899 Org: User:
Start: 01/31/11 End: 12/31/11 Due: 12/31/12

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Phase: N/A Priority: Normal
NCT ID: NCT01206764 Org: User:
Start: 11/11/09 End: 07/01/17 Due: 07/01/18

Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00425555 Org: User:
Start: 01/31/07 End: 06/30/13 Due: 06/30/14

Study to Collect in a Real-world populatIon Data on the Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Hidradenitis Suppurativa (HS) in Routine Clinical Practice in the Russian Federation

Phase: N/A Priority: Normal
NCT ID: NCT06517732 Org: User:
Start: 07/26/24 End: 06/28/26 Due: 06/28/27

Bisphosphonate Treatment of Osteogenesis Imperfecta

Phase: N/A Priority: Normal
NCT ID: NCT00063479 Org: User:
Start: 06/30/03 End: 05/31/07 Due: 05/31/08

A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients

Phase: N/A Priority: Normal
NCT ID: NCT00741377 Org: User:
Start: 01/31/09 End: 12/31/11 Due: 12/31/12

Safety and Exploratory Efficacy of HSC835 in Patients With Inherited Metabolic Disorders (IMD)

Phase: N/A Priority: Normal
NCT ID: NCT02715505 Org: User:
Start: 10/10/17 End: 05/18/20 Due: 05/18/21

Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.

Phase: N/A Priority: Normal
NCT ID: NCT05763875 Org: User:
Start: 03/15/23 End: 06/20/24 Due: 06/20/25

A 24-Week Efficacy, Safety and Tolerability of Rivastigmine Patch Study in Patients With Probable Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01399125 Org: User:
Start: 07/31/11 End: 05/31/13 Due: 05/31/14

Study of PK/PD, Safety and Tolerability of LIK066 in Patients With Decreased Renal Function.

Phase: N/A Priority: Normal
NCT ID: NCT03131479 Org: User:
Start: 04/28/17 End: 01/16/18 Due: 01/16/19

A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

Phase: N/A Priority: Normal
NCT ID: NCT05252585 Org: User:
Start: 05/01/23 End: 02/21/26 Due: 02/21/27